foxo4-dri senolytic 2024 animal model The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI alleviates testosterone secretion insufficiency
FOXO4 DRI alleviates testosterone secretion insufficiency in naturally Download Scientific Diagram Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway
Pay in 4 interest-free payments of $5.82 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16



